Picture of Anteris Technologies logo

AVR Anteris Technologies Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m+1.25%
3m-6.66%
6m+16.4%
1yr+139.43%
Volume Change (%)
10d/3m-16.81%
Price vs... (%)
52w High-25.54%
50d MA-0.02%
200d MA+5.15%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-101.93%
Return on Equity-255.16%
Operating Margin-387.44%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Anteris Technologies EPS forecast chart

Profile Summary

Anteris Technologies Ltd is an Australia-based structural heart company engaged in developing technologies solutions that help healthcare professionals. The Company’s segments include Operations and Projects. The Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. The Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. It offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold that re-engineers xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
June 23rd, 1999
Public Since
March 24th, 2004
No. of Employees
1
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
13,817,563

AVR Share Price Performance

Upcoming Events for AVR

Anteris Technologies Ltd Annual Shareholders Meeting

Similar to AVR

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email